Market Vectors MSCI Emerging Markets Quality ETF QEM 深 滬
已收盤 10-08 16:00:00 美东时间
0.00
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 總市值 0
- 52周最高 0.00
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.00
- 委 比 0.00%
- 總股本 --
- 歷史最高 0.00
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 0.00
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Eisai Co. And Biogen Announce FDA Approval For LEQEMBI IQLIK Subcutaneous Injection For Maintenance Dosing For The Treatment of Early Alzheimer's Disease
TOKYO and CAMBRIDGE, Mass., Aug. 29, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher
08-30 05:08
Biogen And Eisai Report LEQEMBI Slowed Alzheimer's Decline By 1.75 Points Over 4 Years, Preserved Function In 56% of Low-Tau Patients
Data Showed LEQEMBI Slowed Clinical Decline by 1.75 Points on CDR-SB at Four Years Compared to the Natural History of Alzheimer's Disease56% of Patients with Low Tau Continued to Demonstrate Improved Cognitive
07-30 20:09
Reported Earlier, Biogen To Present 48-Month LEQEMBI Clarity AD Data And Subcutaneous Dosing Insights At Alzheimer's Association International Conference 2025
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau to explore its biological role, the development of
07-22 15:02
QEM Limited Announces Director Resignation and Securities Interests
QEM Limited ( ($AU:QEM) ) just unveiled an update. QEM Limited has announced th...
07-02 09:08
QEM Limited Announces Director’s Share Sale
QEM Limited ( ($AU:QEM) ) has issued an announcement. QEM Limited has announced...
06-25 11:17
